Darzalex

Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways
Benzinga
Genmab
JNJ
Janssen
Darzalex
Flag link:
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Clinical Trials Arena
JNJ
Janssen
clinical trials
Darzalex
Revlimid
Velcade
Multiple Myeloma
Flag link:
The patent winter is coming
The patent winter is coming
EP Vantage
patents
biosimilars
patent cliff
Keytruda
Opdivo
Eliquis
Darzalex
Revlimid
Humira
Stelara
AbbVie
Merck
Bristol Myers Squibb
JNJ
Flag link:
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex fight
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex fight
Fierce Pharma
JNJ
Genmab
Darzalex
Multiple Myeloma
drug royalties
Flag link:
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma
Fierce Pharma
ASH2021
Sanofi
JNJ
Sarclisa
Darzalex
Multiple Myeloma
Flag link:
J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval
J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval
Endpoints
JNJ
Sanofi
Multiple Myeloma
Sarclisa
Kyprolis
Darzalex
Flag link:
Non-genetic amyloidosis lives again, thanks to Darzalex and Astra
Non-genetic amyloidosis lives again, thanks to Darzalex and Astra
EP Vantage
AL amyloidosis
Darzalex
AstraZeneca
clinical trials
CAEL-101
Caelum Biosciences
Flag link:
EHA: Johnson & Johnson, nearing Sanofi showdown, bolsters Darzalex's myeloma lead with 'unprecedented' survival data
EHA: Johnson & Johnson, nearing Sanofi showdown, bolsters Darzalex's myeloma lead with 'unprecedented' survival data
Fierce Pharma
JNJ
Darzalex
Multiple Myeloma
Sanofi
Sarclisa
EHA
Flag link:
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission
Pharmaforum
Janssen
Multiple Myeloma
Darzalex
EMA
FDA
Flag link:
J&J's Darzalex Proves Effective in Yet Another Multiple Myeloma Indication
J&J's Darzalex Proves Effective in Yet Another Multiple Myeloma Indication
BioSpace
JNJ
Genmab
clinical trials
Darzalex
Multiple Myeloma
Flag link:
J&J’s next-gen Darzalex sparks drug delivery royalties battle
J&J’s next-gen Darzalex sparks drug delivery royalties battle
Fierce Pharma
JNJ
Darzalex
Genmab
Halozyme
Flag link:
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
BioSpace
Genmab
JNJ
Janssen
Darzalex
arbitration
Multiple Myeloma
Flag link:
J&J adds yet another multiple myeloma regimen to the Darzalex label as Sanofi rival jumps in
J&J adds yet another multiple myeloma regimen to the Darzalex label as Sanofi rival jumps in
Endpoints
JNJ
Darzalex
FDA
Multiple Myeloma
Flag link:
With Sanofi entering the multiple myeloma market, J&J flashes data on new rare disease
With Sanofi entering the multiple myeloma market, J&J flashes data on new rare disease
Endpoints
EHA
JNJ
clinical trials
Darzalex
AL amyloidosis
Flag link:
EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win
EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win
Fierce Pharma
light chain amyloidosis
JNJ
Darzalex
EHA
Flag link:
J&J defends Darzalex with FDA approval for faster dosing
J&J defends Darzalex with FDA approval for faster dosing
Pharmaforum
JNJ
FDA
Darzalex
dosing
Multiple Myeloma
Flag link:
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Motley Fool
JNJ
Janssen
Darzalex
daratumumab
Multiple Myeloma
Flag link:
ASH: J&J's Darzalex cuts death risk by 40% in new myeloma patients
ASH: J&J's Darzalex cuts death risk by 40% in new myeloma patients
Fierce Pharma
JNJ
Darzalex
Multiple Myeloma
ASH2019
Flag link:
J&J's Darzalex makes FDA history with another myeloma nod in new patients
J&J's Darzalex makes FDA history with another myeloma nod in new patients
Fierce Pharma
JNJ
Darzalex
FDA
Multiple Myeloma
Flag link:
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Fierce Pharma
Amgen
Kyprolis
JNJ
Darzalex
Multiple Myeloma
Flag link:

Pages